The effect of chemotherapies on the crosstalk interaction between CD8 cytotoxic T-cells and MHC-I peptides in the microenvironment of WHO grade 4 astrocytoma
Folia Neuropathologica · 2023
DOI: 10.5114/fn.2023.131014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Folia Neuropathologica, 2023. Verfasst von Nadeem Butt und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Faculty of Medicine, King Abdulaziz University, Rabigh, Saudi Arabia. Hauptthemen laut MEDLINE: Brain Neoplasms, Glioblastoma, Astrocytoma. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
INTRODUCTION: CD8 + T-cells and MHC-I have been detected in brain gliomas with a significant outcome. The effect of chemotherapies on the crosstalk interaction between CD8 + T-cells and MHC-I has never been explored. MATERIAL AND METHODS: The protein expression profiling of CD8 cytotoxic T-cells and the gene expression assay of MHC-I in 35 patients diagnosed with WHO grade 4 astrocytoma were performed. The impact of these two factors on tumor recurrence was analyzed. RESULTS: IDH was wildtype in 13 tumors. MHC-I protein expression was absent or low in 34 tumors and dense in a single case. MHC-I gene expression was upregulated in 10 tumors and 25 tumors showed MHC-I gene downregulation. Temozolomide (TMZ) was given to 24 patients and 11 patients received TMZ plus other chemotherapies. No statistically significant association was observed between IDH mutation and CD8 + T-cells ( p = 0.383). However, this association was significant in recurrence-free interval (RFI) ( p = 0.012). IDH-wildtype tumors with highly infiltrated CD8 + T-cells or IDH-mutant tumors with low CD8 + T-cells showed late tumor recurrence. There was a statistically significant difference in RFI between tumors with different MHC-I expression and CD8 + T-cell counts after treatment with TMZ or TMZ plus ( p = 0.026). CONCLUSIONS: No association between IDH mutation and CD8+ cytotoxic T-cell was found. IDH is directly linked to tumor recurrence regardless of CD8 + T-cells infiltration. TMZ plus other adjuvants is proved to be more effective in improving patient survival and delaying tumor recurrence, as compared to using TMZ alone. Nonetheless, none-TMZ adjuvants may increase tumor sensitization to cytotoxic T-cells more than TMZ.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Faculty of Medicine, King Abdulaziz University, Rabigh, Saudi Arabia.
- Department of Surgery, King Abdulaziz University Hospital, Jeddah, Saudi Arabia.
- Department of Neurosurgery, King Fahad General Hospital, Madinah, Saudi Arabia.
- Department of Pathology, College of Medicine, Umm Al-Qura University, Mecca, Saudi Arabia.
- Department of Neurosurgery, King Fahad General Hospital, Jeddah, Saudi Arabia.
- Department of Clinical Physiology, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
Zitieren
APA
Butt, N., Enani, M., Alshanqiti, M., Alkhotani, A., Alsinani, T., Karami, M. M., Fadul, M. M., Almansouri, M., Hassan, A., Baeesa, S., Bamaga, A. K., Alkhayyat, S., Faizo, E., & Kurdi, M. (2023). The effect of chemotherapies on the crosstalk interaction between CD8 cytotoxic T-cells and MHC-I peptides in the microenvironment of WHO grade 4 astrocytoma. Folia Neuropathologica. https://doi.org/10.5114/fn.2023.131014
Vancouver
Butt N, Enani M, Alshanqiti M, Alkhotani A, Alsinani T, Karami MM, et al. The effect of chemotherapies on the crosstalk interaction between CD8 cytotoxic T-cells and MHC-I peptides in the microenvironment of WHO grade 4 astrocytoma. Folia Neuropathologica. 2023. doi:10.5114/fn.2023.131014
BibTeX
@article{Butt2023,
author = {Butt, Nadeem and Enani, Maryam and Alshanqiti, Maryam and Alkhotani, Alaa and Alsinani, Taghreed and Karami, Mohammed Matoog and Fadul, Motaz M and Almansouri, Majid and Hassan, Amber and Baeesa, Saleh and Bamaga, Ahmed K and Alkhayyat, Shadi and Faizo, Eyad and Kurdi, Maher},
title = {The effect of chemotherapies on the crosstalk interaction between CD8 cytotoxic T-cells and MHC-I peptides in the microenvironment of WHO grade 4 astrocytoma},
journal = {Folia Neuropathologica},
year = {2023},
doi = {10.5114/fn.2023.131014}
}
EUVIMED